Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
infectious_diseases_institute [2023/05/17 23:45] liam | infectious_diseases_institute [2024/06/08 20:39] (current) liam [External links] | ||
---|---|---|---|
Line 26: | Line 26: | ||
==== Collaborators ==== | ==== Collaborators ==== | ||
- | IDI has run clinical trials in collaboration with, or is otherwise partnered with or funded by: | + | IDI has run clinical trials in collaboration with, or is otherwise partnered with or funded by: |
<WRAP column col4> | <WRAP column col4> | ||
Line 36: | Line 36: | ||
* [[Africa Centre for Systematic Reviews and Knowledge Translation]] | * [[Africa Centre for Systematic Reviews and Knowledge Translation]] | ||
* [[African Dialogue on AIDS Care]] | * [[African Dialogue on AIDS Care]] | ||
+ | * [[African Network for Drugs and Diagnostics Innovation]] (ANDI) | ||
* [[African Palliative Care Association]] (APCA) | * [[African Palliative Care Association]] (APCA) | ||
* [[Afya Bora Consortium]] | * [[Afya Bora Consortium]] | ||
* [[AIDS Vaccine Advocacy Coalition]] (AVAC) | * [[AIDS Vaccine Advocacy Coalition]] (AVAC) | ||
+ | * [[Airtel]] | ||
* [[medical_technology_companies: | * [[medical_technology_companies: | ||
* [[American International Health Alliance]] (AIHA) | * [[American International Health Alliance]] (AIHA) | ||
Line 50: | Line 52: | ||
* [[Cardno Emerging Markets]] (now [[Emerging Markets International]]) | * [[Cardno Emerging Markets]] (now [[Emerging Markets International]]) | ||
* [[Case Western Reserve University]] | * [[Case Western Reserve University]] | ||
+ | * [[Center for Human Services]] (CHS) | ||
* [[Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases]] | * [[Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases]] | ||
* [[Center for Poverty-Related Communicable Diseases]] | * [[Center for Poverty-Related Communicable Diseases]] | ||
* [[Centers for AIDS Research]] (CFAR) | * [[Centers for AIDS Research]] (CFAR) | ||
* [[Centers for Disease Control and Prevention]] (CDC) | * [[Centers for Disease Control and Prevention]] (CDC) | ||
+ | * [[Central Public Health Laboratories]] (CPHL) | ||
* [[CH2M]] | * [[CH2M]] | ||
* [[Chancellor College]] | * [[Chancellor College]] | ||
* [[Chelsea and Westminster Hospital NHS Foundation Trust]] | * [[Chelsea and Westminster Hospital NHS Foundation Trust]] | ||
* [[Children' | * [[Children' | ||
+ | * [[China-Uganda Friendship Hospital Naguru]] (CUFH-N) | ||
* [[CIHR Canadian HIV Trials Network]] | * [[CIHR Canadian HIV Trials Network]] | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
Line 68: | Line 73: | ||
* [[Department for International Development]] (DFID) | * [[Department for International Development]] (DFID) | ||
* [[Diana, Princess of Wales Memorial Fund]] | * [[Diana, Princess of Wales Memorial Fund]] | ||
+ | * [[Division of Acquired Immunodeficiency Syndrome]] (DAIDS) | ||
* [[Doris Duke Charitable Foundation]] | * [[Doris Duke Charitable Foundation]] | ||
* [[Dr. Ralph and Marian Falk Medical Research Trust]] | * [[Dr. Ralph and Marian Falk Medical Research Trust]] | ||
Line 78: | Line 84: | ||
* [[European & Developing Countries Clinical Trials Partnership]] (EDCCTP) | * [[European & Developing Countries Clinical Trials Partnership]] (EDCCTP) | ||
* [[European Commission]] | * [[European Commission]] | ||
+ | * [[European Research Executive Agency]] (EREA) | ||
* [[ExxonMobil]] | * [[ExxonMobil]] | ||
* [[Family Health International]] | * [[Family Health International]] | ||
Line 93: | Line 100: | ||
* [[Harvard University]] | * [[Harvard University]] | ||
* [[Haughton Institute]] | * [[Haughton Institute]] | ||
+ | * [[Health Research Board]] (HRB) | ||
* [[Health Resources and Services Administration]] (HRSA) | * [[Health Resources and Services Administration]] (HRSA) | ||
+ | * [[HIV Prevention Trials Network]] (HPTN) | ||
* [[Indiana University]] | * [[Indiana University]] | ||
* [[Infectious Diseases Research Collaboration]] (IDRC) | * [[Infectious Diseases Research Collaboration]] (IDRC) | ||
Line 102: | Line 111: | ||
* [[International Development Research Centre]] (IDRC) | * [[International Development Research Centre]] (IDRC) | ||
* [[International Initiative for Impact Evaluation]] (3ie) | * [[International Initiative for Impact Evaluation]] (3ie) | ||
+ | * [[International Maternal Pediatric Adolescent AIDS Clinical Trials Network]] (IMPAACT) | ||
* [[International Society for Infectious Diseases]] | * [[International Society for Infectious Diseases]] | ||
+ | * [[International Training and Education Center for Health]] (I-TECH) | ||
* [[Irish Aid]] | * [[Irish Aid]] | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
Line 118: | Line 129: | ||
* [[Leidos]] | * [[Leidos]] | ||
* [[London School of Hygiene and Tropical Medicine]] | * [[London School of Hygiene and Tropical Medicine]] | ||
+ | * [[Magee-Womens Research Institute and Foundation]] | ||
+ | * [[Mahidol University]] | ||
* [[Makerere University-Johns Hopkins University Research Collaboration]] | * [[Makerere University-Johns Hopkins University Research Collaboration]] | ||
* [[Makerere University School of Medicine]] | * [[Makerere University School of Medicine]] | ||
Line 125: | Line 138: | ||
* [[Malawi Ministry of Health]] | * [[Malawi Ministry of Health]] | ||
* [[Management Sciences for Health]] | * [[Management Sciences for Health]] | ||
+ | * [[Marie Stopes International]] (MSI) | ||
* [[Massachusetts General Hospital]] | * [[Massachusetts General Hospital]] | ||
* [[Medical Research Council]] (MRC) | * [[Medical Research Council]] (MRC) | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
+ | * [[Mérieux Foundation]] | ||
* [[Michigan State University]] | * [[Michigan State University]] | ||
+ | * [[Microbicide Trials Network]] (MTN) | ||
* [[MicroResearch]] | * [[MicroResearch]] | ||
* [[Microsoft Research]] | * [[Microsoft Research]] | ||
Line 137: | Line 153: | ||
* [[National Cancer Institute]] (NCI) | * [[National Cancer Institute]] (NCI) | ||
* [[National Drug Authority]] (NDA) | * [[National Drug Authority]] (NDA) | ||
+ | * [[National Institute of Allergy and Infectious Diseases]] (NIAID) | ||
+ | * [[National Institute of Child Health and Human Development]] (NICHD) | ||
+ | * [[National Institute of Mental Health]] (NIMH) | ||
+ | * [[National Institute of Neurological Disorders and Stroke]] (NINDS) | ||
* [[National Institutes of Health]] (NIH) | * [[National Institutes of Health]] (NIH) | ||
* [[Neurologic AIDS Research Consortium]] | * [[Neurologic AIDS Research Consortium]] | ||
* [[New Hope Project]] | * [[New Hope Project]] | ||
* [[Northwestern University]] | * [[Northwestern University]] | ||
+ | * [[pharmaceutical_companies: | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
+ | * [[Partners Healthcare]] (now called [[Mass General Brigham]]) | ||
+ | * [[Pasteur Institute of Lille]] | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
* [[Pharmaceutical Product Development South Africa]] | * [[Pharmaceutical Product Development South Africa]] | ||
Line 149: | Line 172: | ||
* [[President' | * [[President' | ||
* [[Projet CURE]] | * [[Projet CURE]] | ||
+ | * [[Quintiles Clindepharm]] | ||
* [[Rakai Health Sciences Program]] (RHSP) | * [[Rakai Health Sciences Program]] (RHSP) | ||
* [[RAND Corporation]] | * [[RAND Corporation]] | ||
* [[Realta Global HIV/AIDS Foundation]] | * [[Realta Global HIV/AIDS Foundation]] | ||
+ | * [[Regional AIDS Training Network]] (RATN) | ||
* [[Research and Education Network Uganda]] (RENU) | * [[Research and Education Network Uganda]] (RENU) | ||
* [[Rockefeller Foundation]] | * [[Rockefeller Foundation]] | ||
Line 162: | Line 187: | ||
* [[Stanford University School of Medicine]] | * [[Stanford University School of Medicine]] | ||
* [[Stop TB Partnership]] | * [[Stop TB Partnership]] | ||
+ | * [[Strengthening Decentralization for Sustainability]] (SDS) | ||
* [[Sue & Nick Hellman Foundation]] | * [[Sue & Nick Hellman Foundation]] | ||
* [[Swaziland Health Laboratory Services]] (SHLS) | * [[Swaziland Health Laboratory Services]] (SHLS) | ||
Line 182: | Line 208: | ||
* [[United States Army Medical Research Institute of Infectious Diseases]] (USAMRIID) | * [[United States Army Medical Research Institute of Infectious Diseases]] (USAMRIID) | ||
* [[United States Department of Defense]] (DoD) | * [[United States Department of Defense]] (DoD) | ||
+ | * [[Université libre de Bruxelles]] (ULB) | ||
+ | * [[University of Alabama]] | ||
* [[University of Antwerp]] | * [[University of Antwerp]] | ||
* [[University of California Global Health Institute]] (UCGHI) | * [[University of California Global Health Institute]] (UCGHI) | ||
Line 191: | Line 219: | ||
* [[University of Minnesota]] | * [[University of Minnesota]] | ||
* [[University of Nairobi]] | * [[University of Nairobi]] | ||
+ | * [[University of Nebraska]] | ||
+ | * [[University of North Carolina]] | ||
* [[University of Toronto]] | * [[University of Toronto]] | ||
* [[University of Washington]] | * [[University of Washington]] | ||
Line 196: | Line 226: | ||
* [[University Research Corporation]] (URC) | * [[University Research Corporation]] (URC) | ||
* [[Vanderbilt University Medical Center]] | * [[Vanderbilt University Medical Center]] | ||
+ | * [[VIB]] | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
* [[VLIR-UOS]] | * [[VLIR-UOS]] | ||
+ | * [[Vrije Universiteit Brussel]] | ||
* [[Wellcome Trust]] | * [[Wellcome Trust]] | ||
* [[West African Infectious Diseases Institute]] (WAIDI) | * [[West African Infectious Diseases Institute]] (WAIDI) | ||
Line 209: | Line 241: | ||
===== External links ===== | ===== External links ===== | ||
+ | * [[https:// | ||
* [[https:// | * [[https:// |